Back
VYNE Therapeutics, Inc. Stock Price Chart
AI Powerhouse Raises Price - But Room Remains
DISCLOSURE: This is a paid advertisement for RAD Intel's Reg A offering and involves risk, including the possible loss of principal. Please read the offering circular and related risks at invest.radi
Sell
45
VYNE
VYNE Therapeutics, Inc.
Last Price:
$0.37
Seasonality Move:
-5.82%
7 Day Trial
ALL ACCESS PASS
$
7
$0.85 Entry Open - Fortune 1000 AI Tech in Demand
DISCLOSURE: This is a paid advertisement for RAD Intel's Reg A offering and involves risk, including the possible loss of principal. Please read the offering circular and related risks at invest.radi-
The current trend is relatively stagnant and VYNE is experiencing selling pressure, which indicates risk of future bearish movement.
VYNE Therapeutics, Inc. Price Chart Indicators
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 0.37 | Buy |
| 20-day SMA: | 0.37 | Buy |
| 50-day SMA: | 0.36 | Buy |
| 200-day SMA: | 0.99 | Sell |
| 8-day EMA: | 0.37 | Buy |
| 20-day EMA: | 0.3 | Buy |
| 50-day EMA: | 0.18 | Buy |
| 200-day EMA: | 0.06 | Buy |
VYNE Therapeutics, Inc. Technical Analysis Indicators
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.08 | Buy |
| Relative Strength Index (14 RSI): | 52.82 | Buy |
| Chaikin Money Flow: | -175707 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (0.35 - 0.37) | Buy |
| Bollinger Bands (100): | (0.15 - 0.73) | Sell |
VYNE Therapeutics, Inc. Technical Analysis
| Nov 20 | Nov 21 | Nov 24 | Nov 25 | Nov 26 | Nov 28 | Dec 1 | Dec 2 | Dec 3 | Dec 4 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Nov | Dec | |||||||||
| 20 | 21 | 24 | 25 | 26 | 28 | 01 | 02 | 03 | 04 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Technical Analysis for VYNE Therapeutics, Inc. Stock
Is VYNE Therapeutics, Inc. Stock a Buy?
-
VYNE Therapeutics, Inc. share price is 0.37 while VYNE 8-day simple moving average is 0.37, which is a Buy signal.
-
The stock price of VYNE is 0.37 while VYNE Therapeutics, Inc. 20-day SMA is 0.37, which makes it a Buy.
-
VYNE Therapeutics, Inc. 50-day simple moving average is 0.36 while VYNE share price is 0.37, making it a Buy technically.
-
VYNE stock price is 0.37 and VYNE Therapeutics, Inc. 200-day simple moving average is 0.99, creating a Sell signal.
VYNE Technical Analysis vs Fundamental Analysis
Sell
45
VYNE Therapeutics, Inc. (VYNE)
is a Sell
Is VYNE Therapeutics, Inc. a Buy or a Sell?
-
VYNE Therapeutics, Inc. stock is rated a SellThe current VYNE Therapeutics, Inc. [VYNE] share price is $0.37. The Score for VYNE is 45, which is 10% below its historic median score of 50, and infers higher risk than normal.
VYNE Therapeutics, Inc. Stock Info
Market Cap:
12.5M
Price in USD:
0.37
Share Volume:
395.3K
VYNE Therapeutics, Inc. 52-Week Range
52-Week High:
4.30
52-Week Low:
0.28
Sell
45
VYNE Therapeutics, Inc. (VYNE)
is a Sell
VYNE Therapeutics, Inc. Share Price Forecast
-
What is the VYNE Therapeutics, Inc. stock price today?The VYNE Therapeutics, Inc. stock price is 0.37 USD today.
-
Will VYNE stock go up or go down?VYNE Therapeutics, Inc.> share price is forecast to RISE/FALL based on technical indicators
-
Is VYNE Therapeutics, Inc. overvalued?According to simple moving average, exponential moving average, oscillators, and other technical indicators, VYNE Therapeutics, Inc. is overvalued.
Is VYNE Therapeutics, Inc. Stock a Buy?
-
VYNE Therapeutics, Inc. share price is 0.37 while VYNE 8-day exponential moving average is 0.37, which is a Buy signal.
-
The stock price of VYNE is 0.37 while VYNE Therapeutics, Inc. 20-day EMA is 0.30, which makes it a Buy.
-
VYNE Therapeutics, Inc. 50-day exponential moving average is 0.18 while VYNE share price is 0.37, making it a Buy technically.
-
VYNE stock price is 0.37 and VYNE Therapeutics, Inc. 200-day simple moving average is 0.06, creating a Buy signal.
Fundamental Analysis of VYNE Therapeutics, Inc.
Is VYNE Therapeutics, Inc. a good investment?
-
Analysts estimate an earnings increase this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, an increase this year of $8.36 per share, and a decrease next year of $0.21 per share.
Technical Analysis of VYNE Therapeutics, Inc.
Should I short VYNE Therapeutics, Inc. stock?
-
VYNE Moving Average Covergence Divergence (MACD) indicator is 0.08, suggesting VYNE Therapeutics, Inc. is a Buy
-
VYNE Therapeutics, Inc. Relative Strength Index (RSI) is 52.82, which suggest VYNE Therapeutics, Inc. is overbought
-
The Bollinger Bands (25) for VYNE Therapeutics, Inc. is (0.35 - 0.37), which suggest VYNE Therapeutics, Inc. is a Sell
-
The Bollinger Bands (100) for VYNE Therapeutics, Inc. is (0.15 - 0.73), which suggest VYNE Therapeutics, Inc. is a Sell
* VYNE Therapeutics, Inc. stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.